MIRAGEN THERAPEUTICS, INC.

Profile

Company Names

MIRAGEN THERAPEUTICS, INC.
MIRAGEN THERAPEUTICS INC

Addresses

6200 LOOKOUT ROAD #100, BOULDER, CO 80301

6200 LOOKOUT ROAD, BOULDER, CO 80301

Phone Numbers

(303) 531-5952

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DE

Total Amount Raised:

$105,224,410.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2017-02-13 
$40,703,067.00 
$40,703,067.00 
$0.00 
Equity 
6
2015-10-30 
$24,968,495.00 
$41,059,739.00 
$16,091,244.00 
Equity 
5
2015-02-03 
$8,499,962.00 
$20,000,000.00 
$11,500,038.00 
 
4
2012-04-10 
$12,999,906.00 
$19,999,866.00 
$6,999,960.00 
Equity 
3
2010-09-10 
$6,000,000.00 
$6,000,000.00 
$0.00 
 
2
2009-05-15 
$52,983.00 
$52,983.00 
$0.00 
Equity 
1
2008-05-16 
$11,999,997.00 
$11,999,997.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRUCE 
BOOTH 
EXECUTIVE OFFICER, DIRECTOR
MARVIN 
 
CARUTHERS 
DIRECTOR
MARVIN 
CARUTHERS 
DIRECTOR
JOHN 
W. 
CREECY 
DIRECTOR
THOMAS 
HUGHES 
DIRECTOR
THOMAS 
E. 
HUGHES 
DIRECTOR
KYLE 
A. 
LEFKOFF 
DIRECTOR
JASON 
 
LEVERONE 
EXECUTIVE OFFICER
JASON 
LEVERONE 
EXECUTIVE OFFICER
ADAM 
LEVY 
EXECUTIVE OFFICER
WILLIAM 
S. 
MARSHALL 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHER 
MORL 
EXECUTIVE OFFICER
DAVID 
 
RODMAN 
EXECUTIVE OFFICER
DAVID 
M. 
RODMAN 
EXECUTIVE OFFICER
PAUL 
D. 
RUBIN 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2015-02-03 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2010-09-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2010-09-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-05-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
WEDBUSH SECURITIES INC.
877
WEDBUSH SECURITIES INC.
877